title: Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies.
abstract: One hundred twenty-one adult liver transplant recipients were studied for the incidence, risk factors, and morbidity associated with herpesviruses infections after transplantation. The overall incidence of infection was 59% for cytomegalovirus (CMV), 35% for herpes simplex virus (HSV), 25% for Epstein-Barr virus (EBV), and 7% for varicella-zoster virus (VZV). Primary CMV infection occurred in 46% and reactivation CMV infection in 67% of the susceptible recipients. Symptomatic and disseminated CMV diseases were more common when patients developed primary infection (P less than .01, for both comparisons). The donor organ appeared to be the only important source of CMV infection in seronegative recipients. The use of OKT3 antibodies was associated with disseminated CMV disease in patients with primary infection (P = .04) but not with reactivation infection (P greater than .10). Although most HSV infections were oral or genital reactivations, three cases of HSV hepatitis occurred--one was a primary infection. Symptomatic reactivations of HSV were observed in 53% of HSV-seropositive recipients who received OKT3, versus 31% of seropositive recipients who did not receive OKT3 (P = .05).
authors.affiliation: Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pennsylvania 15261.
authors.forename: N
authors.initials: N
authors.lastname: Singh
authors.forename: J S
authors.initials: JS
authors.lastname: Dummer
authors.forename: S
authors.initials: S
authors.lastname: Kusne
authors.forename: M K
authors.initials: MK
authors.lastname: Breinig
authors.forename: J A
authors.initials: JA
authors.lastname: Armstrong
authors.forename: L
authors.initials: L
authors.lastname: Makowka
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
authors.forename: M
authors.initials: M
authors.lastname: Ho
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000914:Antibodies, Viral / Q000032:analysis; D003586:Cytomegalovirus Infections / Q000453:epidemiology / Q000635:transmission*; D006566:Herpesviridae Infections / Q000453:epidemiology / Q000635:transmission*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D016031:Liver Transplantation; D010414:Pennsylvania; D011183:Postoperative Complications / Q000209:etiology*; D014019:Tissue Donors; D065227:Transfusion Reaction
chemical_list: D000911:Antibodies, Monoclonal; D000914:Antibodies, Viral